Tradewinds Capital Management’s Sana Biotechnology SANA Stock Holding History

Tradewinds Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75	Closed	-$1K	–	715
2022 Q1	$1K	Hold	75	–	–	﹤0.01%	742
2021 Q4	$1K	Hold	75	–	–	﹤0.01%	737
2021 Q3	$2K	Hold	75	–	–	﹤0.01%	668
2021 Q2	$1K	Hold	75	–	–	﹤0.01%	735
2021 Q1	$3K	Buy	+75	New	+$2.44K	﹤0.01%	611

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tradewinds Capital Management's SANA Position: Q2 2022 in Review

Tradewinds Capital Management sold out of Sana Biotechnology (SANA) in Q2 2022, closing a stake of 75 shares — an estimated $1K sold.

Tradewinds Capital Management first reported a position in SANA in Q1 2021 and held it in 5 quarters. The position peaked at $3K in Q1 2021. 116 funds tracked by Wall St. Rank hold SANA as of Q2 2022.

Tradewinds Capital Management reported no remaining Sana Biotechnology position as of Q2 2022 after selling out during the quarter.
Tradewinds Capital Management sold 75 Sana Biotechnology shares in Q2 2022, an estimated $1K.
Tradewinds Capital Management first reported a position in Sana Biotechnology in Q1 2021 and held it in 5 quarters.
Tradewinds Capital Management's Sana Biotechnology position peaked at $3K in Q1 2021.
116 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2022.

Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.